FILTER

FILTERED INTERVIEW RESULTS

Denise Juliano

GROUP VICE PRESIDENT, LIFE SCIENCES, PREMIER INC.
"Our technology and data capabilities help researchers and providers gain insights into health inequities and support strategies and solutions to advance health equity."

Cory Lewis

CEO, PRESIDENT AND CO-FOUNDER, INCOG BIOPHARMA SERVICES
"Wrapping up Q1 in 2023 we are now above 80 employees with a facility that is cGMP production ready and actively manufacturing commercial PPQ batches for one of our biopharma clients."

Aaron Montgomery

PRESIDENT AND CEO, OURAY
"Among our customers, we note a heightened awareness of preventative safety practices. Also, OURAY see a lot of growth in those exceedingly hazardous chemicals such as fluoridated and brominated materials."

Katrin Rupalla

CEO, YMMUNOBIO
"Based on our in vivo data for our lead CEACAM1/5 antibody YB-200, we have obtained orphan drug status from FDA for the treatment of liver cancer."

Stefan Randl & Paul Spencer

HEAD OF DRUG SUBSTANCE (SR), HEAD OF DRUG DELIVERY & PRODUCT (PS), EVONIK HEALTH CARE
"The US leads innovation, so if you are not heavily invested there in pharma, you are in trouble. Lots of our clients are shifting their production from Asia, so the US will remain critical to Evonik Health Care’s growth."

Roger Erickson

CEO AND FOUNDER, INTERBIOME
"We want to pioneer a commodity utility approach for needed areas of pharmaceutical manufacturing, and make that available as a sustainable platform that any country can start with and innovate from."

Jan Kengelbach

CEO, AENOVA GROUP
"Experienced CDMOs can provide companies with access to new formulation and technology methods that improve the bioavailability of difficult-to-formulate compounds."

Donna LaVoie

PRESIDENT AND CEO, LAVOIEHEALTHSCIENCE
"Companies should be ready to address hostile short-selling and unsolicited takeover bids, develop rapid responses to special meetings and activist demands, and vigorously engage with institutional shareholders, proxy advisory firms, and potential regulators."

Daniel Prince

CEO, PRINCE STERILIZATION SERVICES
"The expansion will allow Prince to more than double its headcount, increase manufacturing capacity, and offer additional ready-to-use products and sterilization services to the market."

Jason Latkowcer

PRESIDENT, CEO AND DIRECTOR, PAN AMERICAN ENERGY CORP.
"Proving commercially viable lithium mineralization has the potential for tremendous value generation for investors."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Africa Energy 2025 - Pre-release

This pre-release, containing insights from executives across leading African upstream, downstream, financing, and service providers, spotlights developments in local capabilities, infrastructure, and new projects that are driving change in some of Africa's most interesting oil and gas producing countries. 

PARTNER EVENTS